Philadelphia, PA · Founded 2017 · Privately Held (backing)
Developer of non-nucleotide small-molecule inhibitors designed for the treatment of cancer and infectious diseases. Avammune Therapeutics is based in Philadelphia, PA and was founded in 2017. Its last reported valuation was $33 million in May 2025. It has raised $18.5 million.
These 7 firms already write checks for companies like Avammune Therapeutics. Build the wider list: every firm that has backed a company like this one, ranked by how often and how recently.